TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Framework for Natalizumab-February 2024

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Natalizumab-February 2024". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
66.2Bids / Report
11.9% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 515 active published awards; 512 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published2 Feb 2024, 13:04 GMT
Last source update2 Feb 2024, 13:04 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-041149
What is being bought
NHS National Framework for Natalizumab - February 2024<br/>Offer reference number: CM/PHR/23/5701<br/>Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
What changed
From the official release history
  1. tender value changed
    2 Feb 2024, 13:04 GMT
  2. Status changed to complete
    2 Feb 2024, 13:04 GMT
  3. Official notice release published
    2 Feb 2024, 13:04 GMT
  4. Submission deadline changed to published date
    2 Feb 2024, 13:04 GMT
  5. Buyer information updated
    2 Feb 2024, 13:04 GMT
  6. Published value updated to £175,000,000
    2 Nov 2023, 14:25 GMT
  7. Status changed to active
    2 Nov 2023, 14:25 GMT
  8. Official notice release published
    2 Nov 2023, 14:25 GMT
  9. Submission deadline changed to 4 Dec 2023, 13:00 GMT
    2 Nov 2023, 14:25 GMT
  10. Buyer information updated
    2 Nov 2023, 14:25 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    NHS National Framework for Natalizumab - February 2024<br/>Offer reference number: CM/PHR/23/5701<br/>Period of framework: 1 February 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    2 Feb 2024, 13:04 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Contract active
    Signed 5 Jan 2024, 00:00 GMT · £1
  5. Contract active
    Signed 5 Jan 2024, 00:00 GMT · £1
Commercial outcome and competition
Awards
Sandoz Ltd
Not published · Not published · active
Biogen
Not published · Not published · active
Contracts
Contract
£1 · signed 5 Jan 2024, 00:00 GMT · active
Contract
£1 · signed 5 Jan 2024, 00:00 GMT · active
Bid statistics
bids: 2 (lot 1)
bids: 2 (lot 1)
electronicBids: 2 (lot 1)
electronicBids: 2 (lot 1)
foreignBidsFromEU: 2 (lot 1)
foreignBidsFromEU: 2 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 1 (lot 1)
smeBids: 1 (lot 1)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-67205
View buyer profile

  • NHS England
    buyer
    centralPurchasingBody

    1st Floor, Quarry House, Quarry Hill, Leeds, UKE, LS2 7UE
    katie.noonan@nhs.net

  • Biogen
    supplier

    01497267
    Biogen Building 5 Foundation Park, Roxborough Way, ,, Maidenhead, Berkshire, England, UK, SL6 3UD

  • Sandoz Ltd
    supplier

    01547204
    Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., UK, GU15 3YL

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published